[Form 4] Resideo Technologies, Inc. Insider Trading Activity
Michael Carlet, Chief Financial Officer of Resideo Technologies, Inc. (REZI), reported a sale of 2,334 shares of the company's common stock on 08/15/2025 at a price of $31.60 per share. Following this transaction he beneficially owned 158,527 shares. The Form 4 was signed by an attorney-in-fact on 08/19/2025.
Michael Carlet, Direttore finanziario di Resideo Technologies, Inc. (REZI), ha venduto 2.334 azioni dell'azione ordinaria della società il 15/08/2025 al prezzo di $31,60 per azione. Dopo questa operazione era titolare beneficiario di 158,527 azioni. Il Modulo 4 è stato firmato da un procuratore il 19/08/2025.
Michael Carlet, Director Financiero de Resideo Technologies, Inc. (REZI), informó la venta de 2.334 acciones del capital social de la compañía el 15/08/2025 a un precio de $31.60 por acción. Tras esta operación poseía de forma beneficiaria 158,527 acciones. El Formulario 4 fue firmado por un apoderado el 19/08/2025.
Resideo Technologies, Inc. (REZI)� 최고재무책임�(CFO) Michael Carlet� 2025-08-15� 회사 보통� 2,334주를 주당 $31.60� 매각했다� 신고했습니다. � 거래 � 그는 실질적으� 158,527주를 보유하고 있었습니�. Form 4� 2025-08-19� 대리인� 의해 서명되었습니�.
Michael Carlet, directeur financier de Resideo Technologies, Inc. (REZI), a déclaré la vente de 2 334 actions ordinaires de la société le 15/08/2025 au prix de 31,60 $ par action. Après cette opération, il détenait à titre bénéficiaire 158,527 actions. Le formulaire 4 a été signé par un mandataire le 19/08/2025.
Michael Carlet, Chief Financial Officer von Resideo Technologies, Inc. (REZI), meldete am 15.08.2025 den Verkauf von 2.334 Aktien des Stammkapitals des Unternehmens zu einem Preis von $31,60 je Aktie. Nach dieser Transaktion besaß er wirtschaftlich 158,527 Aktien. Das Formular 4 wurde am 19.08.2025 von einem Bevollmächtigten unterschrieben.
- None.
- None.
Insights
TL;DR: Insider sale of 2,334 shares, leaving 158,527 shares owned; routine disclosure with limited investor impact.
The reported sale is a small, non-derivative disposition by the CFO and does not include any accompanying commentary about intent or plans. The transaction size relative to total reported holdings appears modest and there are no derivative or exercise events disclosed. This Form 4 documents compliance with Section 16 reporting requirements rather than signaling a material corporate change.
TL;DR: Properly executed Form 4 filing for an officer sale; disclosure appears complete and timely.
The form identifies the reporting person, relationship to the issuer as CFO, the transaction date, transaction code and price, and the post-transaction beneficial ownership. The signature by an attorney-in-fact is provided. There are no indications of rule 10b5-1 plan filings or additional agreements in this filing.
Michael Carlet, Direttore finanziario di Resideo Technologies, Inc. (REZI), ha venduto 2.334 azioni dell'azione ordinaria della società il 15/08/2025 al prezzo di $31,60 per azione. Dopo questa operazione era titolare beneficiario di 158,527 azioni. Il Modulo 4 è stato firmato da un procuratore il 19/08/2025.
Michael Carlet, Director Financiero de Resideo Technologies, Inc. (REZI), informó la venta de 2.334 acciones del capital social de la compañía el 15/08/2025 a un precio de $31.60 por acción. Tras esta operación poseía de forma beneficiaria 158,527 acciones. El Formulario 4 fue firmado por un apoderado el 19/08/2025.
Resideo Technologies, Inc. (REZI)� 최고재무책임�(CFO) Michael Carlet� 2025-08-15� 회사 보통� 2,334주를 주당 $31.60� 매각했다� 신고했습니다. � 거래 � 그는 실질적으� 158,527주를 보유하고 있었습니�. Form 4� 2025-08-19� 대리인� 의해 서명되었습니�.
Michael Carlet, directeur financier de Resideo Technologies, Inc. (REZI), a déclaré la vente de 2 334 actions ordinaires de la société le 15/08/2025 au prix de 31,60 $ par action. Après cette opération, il détenait à titre bénéficiaire 158,527 actions. Le formulaire 4 a été signé par un mandataire le 19/08/2025.
Michael Carlet, Chief Financial Officer von Resideo Technologies, Inc. (REZI), meldete am 15.08.2025 den Verkauf von 2.334 Aktien des Stammkapitals des Unternehmens zu einem Preis von $31,60 je Aktie. Nach dieser Transaktion besaß er wirtschaftlich 158,527 Aktien. Das Formular 4 wurde am 19.08.2025 von einem Bevollmächtigten unterschrieben.